Lotuxs Laser Limited – Trademark Portfolio
Entity Type: 99
Lotuxs Laser Limited owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as NICETOP, SILKPRO, DERMRAYS, SILKPRO USA, and DERMRAYS BY SILKPRO. Of these, 6 are registered and 2 are pending. The portfolio spans 5 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 3 (Cosmetics & Cleaning). Headquartered in Hong Kong.
20 AUSTIN AVENUE TST KL
UNIT 1002?10/F PERFECT COMM BLDG
Hong Kong 999077 , CN
Showing of trademarks Trademarks
Trademark Classifications
Lotuxs Laser Limited's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Lotuxs Laser Limited have?
Lotuxs Laser Limited has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending, 1 abandoned.
What trademark classes does Lotuxs Laser Limited file in?
Lotuxs Laser Limited files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning), Class 8 (Hand Tools), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Lotuxs Laser Limited's most well-known trademarks?
Lotuxs Laser Limited's registered trademark portfolio includes well-known marks such as NICETOP, SILKPRO, DERMRAYS, SILKPRO USA, and DERMRAYS BY SILKPRO. These are among 6 currently registered trademarks in the portfolio.
What is Lotuxs Laser Limited's trademark registration success rate?
Lotuxs Laser Limited has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 2 applications are pending review.